Good News | Heer Medical Certified as Hubei Province's 7th Batch of Specialized and Sophisticated SME

To enhance the innovation capability and specialized development level of small and medium-sized enterprises (SMEs) and promote the high-quality development of specialized and sophisticated SMEs, the Hubei Provincial Department of Economy and Information Technology recently organized the 7th batch of provincial-level Specialized and Sophisticated SME certification. Following initial review and recommendation by municipal and prefectural economic and information departments, expert panel review, and other procedures, the Provincial Department of Economy and Information Technology published the list of selected enterprises, and Wuhan Heer Medical Technology Development Co., Ltd. was honored to be included.

Specialized and Sophisticated enterprises are SMEs characterized by "specialization, refinement, uniqueness, and novelty." These enterprises cultivate deep expertise in specific niche areas, leveraging long-accumulated professional knowledge, technology, and experience to create core products or services with high competitiveness within the industry. They play an important role in strengthening, solidifying, and stabilizing the industrial chain.

Wuhan Heer Medical Technology Development Co., Ltd., established in 2006, is a wholly-owned subsidiary of Boai Xinkaiyuan Medical Technology Group Co., Ltd. (stock code: 300109). It is a high-tech enterprise with independent innovation capabilities and proprietary intellectual property rights.

The company has always focused on the full industry chain deployment of early tumor screening, with early tumor screening as its core, covering equipment research and development, reagent production, technical support, personnel training, equipment maintenance, and other full-process services, dedicated to becoming an integrated comprehensive solution provider. The company consistently adheres to independent research and development and technological innovation, having developed more than 30 hardware and software patented devices and over 100 types of diagnostic reagents/consumables. The company has always practiced the social value of "technology leading, benefiting humanity," with products integrating digital slide scanning technology, AI-assisted diagnosis, remote pathology consultation, and other functions to empower smart pathology construction and alleviate the shortage of primary medical resources.